Compare DAO & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAO | ACHC |
|---|---|---|
| Founded | 2006 | 2005 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2019 | 2011 |
| Metric | DAO | ACHC |
|---|---|---|
| Price | $11.28 | $27.68 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $22.27 |
| AVG Volume (30 Days) | 53.6K | ★ 2.4M |
| Earning Date | 05-14-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,312,769,000.00 |
| Revenue This Year | $12.24 | $5.08 |
| Revenue Next Year | $14.60 | $5.98 |
| P/E Ratio | $72.35 | ★ N/A |
| Revenue Growth | N/A | ★ 5.04 |
| 52 Week Low | $8.00 | $11.43 |
| 52 Week High | $12.96 | $28.47 |
| Indicator | DAO | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 65.73 | 63.38 |
| Support Level | $8.56 | $23.02 |
| Resistance Level | $11.37 | $27.74 |
| Average True Range (ATR) | 0.63 | 1.09 |
| MACD | 0.13 | -0.06 |
| Stochastic Oscillator | 95.50 | 72.74 |
Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.